Cyclopentobarbital (5) [HRP]

Product Overview

Cyclopentobarbital (5), HRP conjugate

Target

Cyclopentobarbital sodium

Nature

Synthetic

Tag/Conjugate

HRP

Format

Concentrate

Preservative

None

Storage

2-8°C short term, -20°C long term

Introduction

Cyclopentobarbital sodium (Cyclopal, Dormisan) is a barbiturate derivative invented in the 1940s. It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine. Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.

Antigen Description

Barbiturates are a class of around 12 compounds derivatised from barbituric acid. They are central nervous system (CNS) depressants and can be used as sedatives, hypnotics, anaesthetics and anti-epileptic drugs. Barbiturates can be divided into three main groups according to their duration of action. The ultra-short-acting barbiturates are used clinically as anaesthetics whilst the long-acting barbiturates have anti-convulsant properties. The short-acting compounds are typically used as hypnotics. The short-acting barbiturates are extensively metabolised by the liver to more pharmacologically inactive hydroxylated compounds.

Keywords

Cyclopentobarbital; Allylpental; Cyclopental; Cyclopal; Ciclopal